Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Biomerica signed a Master Services Agreement with a confidential life sciences partner to develop proprietary IVD assays. The deal carries an initial target fee of $1.75 million, to be earned over a three-year term with automatic renewals.
Key figures
- Contract value
- 1750000
- Contract term years
- 3
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.